The role of fibrinogen in trauma-induced coagulopathy

Hamostaseologie

Volumn 34, Issue 1, 2014, Pages 29-39

  Schlimp, C J ^a   Schochl H ^a,b  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b AUVA Trauma Centre   (Austria)

Author keywords

Coagulopathy; Fibrinogen; Trauma

Indexed keywords

FIBRINOGEN; FIBRINOGEN CONCENTRATE; BLOOD CLOTTING FACTOR;

ACIDOSIS; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BODY TEMPERATURE; CRYOPRECIPITATE; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN METABOLISM; FIBRINOLYSIS; HEMODILUTION; HUMAN; HYPERFIBRINOLYSIS; HYPOTHERMIA; INJURY; PRACTICE GUIDELINE; PROTEIN FUNCTION; THROMBOCYTE COUNT; VISCOELASTICITY; BIOLOGICAL MODEL; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; COMPLICATION; METABOLISM;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; FIBRINOGEN; HUMANS; MODELS, CARDIOVASCULAR; WOUNDS AND INJURIES;

EID: 84896277399     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.5482/HAMO-13-07-0038     Document Type: Article

References (105)

1. Adam S, Karger R, Kretschmer V. Influence of different hydroxyethyl starch (HES) formulations on fibrinogen measurement in HES-diluted plasma. Clin Appl Thromb Hemost 2010; 16: 454-460.
2. Adam S, Karger R, Kretschmer V. Photo-optical methods can lead to clinically relevant overestimation of fibrinogen concentration in plasma diluted with hydroxyethyl starch. Clin Appl Thromb Hemost 2010; 16: 461-471.
3. Bolliger D, Szlam F, Molinaro RJ et al. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution. Br J Anaesth 2009; 102: 793-799.
4. Borgman MA, Spinella PC, Holcomb JB et al. The effect of FFP:RBC ratio on morbidity and mortality in trauma patients based on transfusion prediction score. Vox Sang 2011; 101: 44-54.
5. Brenni M, Worn M, Bruesch M et al. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. Acta Anaesthesiol Scand 2010; 54: 111-117.
6. Brohi K, Cohen MJ, Ganter MT et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245: 812-818.
7. Callum JL, Karkouti K, Lin Y. Cryoprecipitate: the current state of knowledge. Transfus Med Rev 2009; 23: 177-188.
8. Carroll RC, Craft RM, Langdon RJ et al. Early evaluation of acute traumatic coagulopathy by thrombelastography. Transl Res 2009; 154: 34-39.
9. Chambers LA, Chow SJ, Shaffer LE. Frequency and characteristics of coagulopathy in trauma patients treated with a low-or high-plasma-content massive transfusion protocol. Am J Clin Pathol 2011; 136: 364-370.
10. Chandler WL, Ferrell C, Trimble S, Moody S. Development of a rapid emergency hemorrhage panel. Transfusion 2010; 50: 2547-2552.
11. Charbit B, Mandelbrot L, Samain E et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-273.
12. Chowdhury P, Saayman AG, Paulus U et al. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73.
13. Ciavarella D, Reed RL, Counts RB et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67: 365-368.
14. Corum LE, Hlady V. The effect of upstream platelet-fibrinogen interactions on downstream adhesion and activation. Biomaterials 2011; (AUTOR BITTE ERGÄNZEN).
15. CosgriffN, Moore EE, Sauaia A et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient. J Trauma 1997; 42: 857-862.
16. Cotton BA, Harvin JA, Kostousouv V et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg 2012; 73: 365-370.
17. Counts RB, Haisch C, Simon TL et al. Hemostasis in massively transfused trauma patients. Ann Surg 1979; 190: 91-99.
18. Darlington DN, Kheirabadi BS, Delgado AV et al. Coagulation changes to systemic acidosis and bicarbonate correction in Swine. J Trauma 2011; 71: 1271-1277.
19. Davenport R, Curry N, Manson J et al. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1:2. J Trauma 2011; 70: 90-95.
20. Davenport R, Manson J, De'ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652-2658.
21. De Lorenzo C, Calatzis A, Welsch U, Heindl B. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006; 102: 1194-200.
22. Dickneite G, Pragst I, Joch C, Bergman GE. Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate. Blood Coagul Fibrinolysis 2009; 20: 535-540.
23. Dunn EL, Moore EE, Breslich DJ, Galloway WB. Acidosis-induced coagulopathy. Surg Forum 1979; 30: 471-473.
24. Dzik WH, Blajchman MA, Fergusson D et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products -Massive Transfusion Consensus Conference 2011. Crit Care 2011; 15: 242.
25. Fenger-Eriksen C, Anker-Moller E, Heslop J et al. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005; 94: 324-329.
26. Fenger-Eriksen C, Tonnesen E, Ingerslev J, Sorensen B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost 2009; 7: 1099-1105.
27. Fenger-Eriksen C, Ingerslev J, Sorensen B. Fibrinogen concentrate -a potential universal hemo -static agent. Expert Opin Biol Ther 2009; 9: 1325-1333.
28. Fenger-Eriksen C, Moore GW, Rangarajan S et al. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion 2010; 50: 2571-2576.
29. Floccard B, Rugeri L, Faure A et al. Early coagulopathy in trauma patients. Injury 2010; 42: 697-701.
30. Fries D, Innerhofer P, Reif C et al. The effect of fibrinogen substitution on reversal of dilutional coagulopathy. Anesth Analg 2006; 102: 347-351.
31. Fries D, Innerhofer P, Perger P et al. Coagulation management in trauma-related massive bleeding. Anasthesiol Intensivmed Notfallmed Schmerzther 2010; 45: 552-561.
32. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105: 116-121.
33. Goodnight SH, Kenoyer G, Rapaport SI et al. Defibrination after brain-tissue destruction. N Engl J Med 1974; 290: 1043-1047.
34. Groner A. Reply. Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen. Haematologica 2007; 92: 846-849. Haematologica 2008; 93: e24-e26.
35. Grottke O, Braunschweig T, Henzler D et al. Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care 2010; 14: R62.
36. Haas T, Fries D, Velik-Salchner C et al. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg 2008; 106: 1360-1365.
37. Hartog CS, Reuter D, Loesche W et al. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis. Intensive Care Med 2011; 37: 1725-1737.
38. Hess JR, Lawson JH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 2006; 60 (6 Suppl): S12-S19.
39. Hess JR, Brohi K, Dutton RP et al. The coagulopathy of trauma. J Trauma 2008; 65: 748-754.
40. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-365.
41. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagul Fibrinolysis 1995; 6: 743-746.
42. Hunt BJ, Segal H. Hyperfibrinolysis. J Clin Pathol 1996; 49: 958.
43. Inaba K, Branco BC, Rhee P et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210: 957-965.
44. Inaba K, Karamanos E, Lustenberger T et al. Impact of fibrinogen levels on outcomes after acute injury in patients requiring a massive transfusion. J Am Coll Surg 2013; 216: 290-297.
45. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009; 17: 45.
46. Karlsson M, Ternstrom L, Hyllner M et al. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery. Transfusion 2008; 48: 2152-2158.
47. Kashuk JL, Moore EE, Sawyer M et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010; 252: 434-442.
48. Ketchum L, Hess JR, Hiippala S. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 2006; 60 (6 Suppl): S51-S58.
49. Korte W. F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 2010; 24: 85-93.
50. Kozek-Langenecker SA, Afshari A et al. Management of severe perioperative bleeding. Eur J Anaesthesiol 2013; 30: 270-382.
51. Kushimoto S, Shibata Y, Yamamoto Y. Implications of fibrinogenolysis in patients with closed head injury. J Neurotrauma 2003; 20: 357-363.
52. Lang T, Johanning K, Metzler H et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009; 108: 751-758.
53. Lawson JH, Murphy MP. Challenges for providing effective hemostasis in surgery and trauma. Semin Hematol 2004; 41 (1 Suppl 1): 55-64.
54. Levrat A, Gros A, Rugeri L et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008; 100: 792-797.
55. Lowe GD, Rumley A, Mackie IJ. Plasma fibrinogen. Ann Clin Biochem 2004; 41 (Pt 6): 430-440.
56. Mackie IJ, Kitchen S, Machin SJ, Lowe GD. Guidelines on fibrinogen assays. Br J Haematol 2003; 121: 396-404.
57. Maegele M, Lefering R, Yucel N et al. Early coagulopathy in multiple injury. Injury 2007; 38: 298-304.
58. Martini WZ, Pusateri AE, Uscilowicz JM et al. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma 2005; 58: 1002-1009.
59. Martini WZ, Holcomb JB. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg 2007; 246: 831-835.
60. Martini WZ. The effects of hypothermia on fibrinogen metabolism and coagulation function in swine. Metabolism 2007; 56: 214-221.
61. Martinowitz U, Michaelson M. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding. J Thromb Haemost 2005; 3: 640-648.
62. McLoughlin TM, Fontana JL, Alving B et al. Profound normovolemic hemodilution. Anesth Analg 1996; 83: 459-465.
63. Meyer M. Molecular biology of haemostasis: fibrinogen, factor XIII. Hämostaseologie 2004; 24: 108-115.
64. Meyer MA, Ostrowski SR, Windelov NA, Johansson PI. Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang 2011; 101: 185-190.
65. Morrison JJ, Ross JD, Dubose JJ et al. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury. JAMA Surg 2013; 148: 218-225.
66. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-1904.
67. Nascimento B, Callum J, Rubenfeld G et al. Clinical review: Fresh frozen plasma in massive bleedings -more questions than answers. Crit Care 2010; 14: 202.
68. Nascimento B, Rizoli S, Rubenfeld G et al. Cryo -precipitate transfusion. Transfus Med 2011; 21: 394-401.
69. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
70. Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009; 67: 266-275.
71. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2011: CD000567.
72. Practice guidelines for perioperative blood transfusion and adjuvant therapies. Anesthesiology 2006; 105: 198-208.
73. Rahe-Meyer N, Sorensen B. For: Fibrinogen concentrate for management of bleeding. J Thromb Haemost 2011; 9: 1-5.
74. Rahe-Meyer N, Solomon C, Hanke A et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery. Anesthesiology 2013; 118: 40-50.
75. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10: 1342-1351.
76. Savry C, Quinio P, Lefevre F, Schmitt F. Manageability and potential for haemostasis monitoring by near-patient modified thromboelastometer in intensive care unit. Ann Fr Anesth Reanim 2005; 24: 607-616.
77. Schaden E, Hoerburger D, Hacker S et al. Fibrinogen function after severe burn injury. Burns 2011; 38: 77-82.
78. Schlimp CJ, Cadamuro J, Solomon C et al. The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfus 2012: 1-9.
79. Schlimp CJ, Voelckel W, Inaba K et al. Estimation of plasma fibrinogen levels based on hemoglobin, base excess and ISS upon emergency room admission. Crit Care 2013; 17: R137.
80. Schöchl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma. J Trauma 2009; 67: 125-131.
81. Schöchl H, Forster L, Woidke R et al. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia 2010; 65: 199-203.
82. Schöchl H, Nienaber U, Hofer G et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.
83. Schöchl H, Nienaber U, Maegele M et al. Transfusion in trauma. Crit Care 2011; 15: R83.
84. Schöchl H, Cotton B, Inaba K et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011; 15: R265.
85. Schöchl H, Solomon C, Traintinger S et al. Thromboelastometric (ROTEM) findings in patients suffering from isolated severe traumatic brain injury. J Neurotrauma 2011; 28: 2033-2041.
86. Schöchl H, Voelckel W, Maegele M Solomon C. Trauma-associated hyperfibrinolysis. Hämostaseologie 2011; 32: ? (AUTOR BITTE PRÜFEn)???.
87. Solomon C, Pichlmaier U, Schoechl H et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010; 104: 555-562.
88. Solomon C, Rahe-Meyer N, Sorensen B. Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery. Thromb Res 2011; 128: 277-282.
89. Solomon C, Cadamuro J, Ziegler B et al. A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion 2011; 51: 1695-1706.
90. Solomon C, Sorensen B, Hochleitner G et al. Comparison of whole blood fibrin-based clot tests in thrombelastography and thromboelastometry. Anesth Analg 2012; 114: 721-730.
91. Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149: 834-843.
92. Spahn DR, Bouillon B, Cerny V et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2013; 17: R76.
93. Stinger HK, Spinella PC, Perkins JG et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64 (2 Suppl): S79-S85.
94. Tauber H, Innerhofer P, Breitkopf R et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma. Br J Anaesth 2011; 107: 378-387.
95. Theusinger OM, Wanner GA, Emmert MY et al. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg 2011; 113: 1003-1012.
96. Theusinger OM, Baulig W, Seifert B et al. Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and freshfrozen plasma. Br J Anaesth 2011; 106: 505-511.
97. Toulon P, Ozier Y, Ankri A et al. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. Thromb Haemost 2009; 101: 394-401.
98. Velik-Salchner C, Haas T, Innerhofer P et al. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 2007; 5: 1019-1025.
99. Von Heymann C, Keller MK et al. Activity of clotting factors in fresh-frozen plasma during storage at 4 degrees C over 6 days. Transfusion 2009; 49: 913-920.
100. Watson GA, Sperry JL, Rosengart MR et al. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009; 67: 221-227.
101. Weisel JW, Nagaswami C, Vilaire G, Bennett JS. Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy. J Biol Chem 1992; 267: 16637-16643.
102. Weiss G, Lison S, Glaser M et al. Observational study of fibrinogen concentrate in massive hemorrhage. Blood Coagul Fibrinolysis 2011; 22: 727-734.
103. White NJ, Martin EJ, Brophy DF, Ward KR. Coagulopathy and traumatic shock. Resuscitation 2010; 81: 111-116.
104. Wigginton JG, Roppolo L, Pepe PE. Advances in resuscitative trauma care. Minerva Anestesiol 2011; 77: 993-1002.
105. Ziegler B, Schimke C, Marchet P et al. Severe pediatric blunt trauma--successful ROTEMguided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets. Clin Appl Thromb Hemost 2013; 9: 453-459.